^
BIOMARKER:

GNAQ mutation

i
Other names: GNAQ, G Protein Subunit Alpha Q, Guanine Nucleotide Binding Protein (G Protein) Q Polypeptide, Guanine Nucleotide-Binding Protein G(Q) Subunit Alpha, Guanine Nucleotide-Binding Protein Alpha-Q, GAQ, Epididymis Secretory Sperm Binding Protein, G-ALPHA-Q, CMC1, SWS
Entrez ID:
Related biomarkers:
Phase 2
National Cancer Institute (NCI)
Active, not recruiting
Last update posted :
07/26/2021
Initiation :
02/25/2016
Primary completion :
01/31/2022
GNAQ • GNA11
|
GNAQ mutation • GNA11 mutation
|
Mekinist (trametinib)
Phase 2
National Cancer Institute (NCI)
Recruiting
Last update posted :
02/23/2021
Initiation :
04/20/2012
Primary completion :
06/30/2022
BCL2 • GNAQ • GNA11 • BAP1
|
GNAQ mutation • GNA11 mutation • BAP1 mutation
|
Zolinza (vorinostat)
Phase N/A
Institut Curie
Completed
Last update posted :
08/07/2020
Initiation :
09/01/2014
Primary completion :
02/25/2020
Completion :
02/25/2020
GNAQ • GNA11
|
GNAQ mutation • GNA11 mutation
Phase 2
GlaxoSmithKline
Withdrawn
Last update posted :
12/12/2017
Initiation :
11/01/2010
Primary completion :
08/01/2011
Completion :
05/01/2012
GNAQ • GNA11
|
GNAQ mutation • GNA11 mutation
|
Mekinist (trametinib)
Phase 2
National Cancer Institute (NCI)
Completed
Last update posted :
07/26/2017
Initiation :
06/01/2010
Primary completion :
05/01/2016
Completion :
05/01/2016
GNAQ • GNA11 • CYP1A2
|
GNAQ mutation
|
Koselugo (selumetinib) • temozolomide • dacarbazine